About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [963 citations: 1–100 of 845 articles]

Articles published in Parkinson’s Disease have been cited 963 times. The following is a list of the 845 articles that have cited the articles published in Parkinson’s Disease.

  • Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle, Kori Kosberg, Michael Mante, Edward Rockenstein, Margarita Trejo, and Eliezer Masliah, “Environmental neurotoxic challenge of conditional alpha-synuclein transgeni c mice predicts a dopaminergic olfactory-striatal interplay in early PD,” Acta Neuropathologica, vol. 127, no. 4, pp. 477–494, 2014. View at Publisher · View at Google Scholar
  • Swati Haldar, Ajai K. Tripathi, Katharine Horback, Joseph Wong, Deepak Sharma, Amber Beserra, Srinivas Suda, Charumathi Anbalagan, Som Dev, Chinmay K. Mukhopadhyay, and Ajay Singh, “Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities,” Antioxidants & Redox Signaling, vol. 20, no. 8, pp. 1324–1363, 2014. View at Publisher · View at Google Scholar
  • Francesco Cordici, Carmelo Genovese, and Placido Bramanti, “Choline Associated Hypersexuality in a 79-Year-Old Man,” Archives of Sexual Behavior, vol. 43, no. 1, pp. 187–189, 2014. View at Publisher · View at Google Scholar
  • Alberto Costa, Antonella Peppe, Ilenia Mazzù, Mariachiara Longarzo, Carlo Caltagirone, and Giovanni A. Carlesimo, “Dopamine Treatment and Cognitive Functioning in Individuals with Parkinson’s Disease: The “Cognitive Flexibility” Hypothesis Seems to Work,” Behavioural Neurology, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Rochelle S. Zak, Caryl L. Gay, Clive R. Pullinger, Kathryn A. Lee, and Bradley E. Aouizerat, “Polymorphisms of Interleukin-1 Beta and Interleukin-17Alpha Genes Are Assoc iated With Restless Legs Syndrome,” Biological Research for Nursing, vol. 16, no. 2, pp. 143–151, 2014. View at Publisher · View at Google Scholar
  • Yasir Hasan Siddique, Falaq Naz, and Smita Jyoti, “Effect of Curcumin on Lifespan, Activity Pattern, Oxidative Stress, and Apoptosis in the Brains of Transgenic Drosophila Model of Parkinson’s Disease,” BioMed Research International, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Wei-Che Lin, Nai-Wen Tsai, Yung-Cheng Huang, Kuei-Yueh Cheng, Hsiu-Ling Chen, Shau-Hsuan Li, Chia-Te Kung, Yu-Jih Su, Wei-Ming Lin, Meng-Hsiang Chen, Tsui-Min Chiu, I-Hsiao Yang, and Cheng-Hsien Lu, “Peripheral Leukocyte Apoptosis in Patients with Parkinsonism: Correlation with Clinical Characteristics and Neuroimaging Findings,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Beata Lindholm, Peter Hagell, Oskar Hansson, and Maria H Nilsson, “Factors associated with fear of falling in people with Parkinson’s disease,” BMC Neurology, vol. 14, no. 1, pp. 19, 2014. View at Publisher · View at Google Scholar
  • L. Christopher, Y. Koshimori, A. E. Lang, M. Criaud, and A. P. Strafella, “Uncovering the role of the insula in non-motor symptoms of Parkinson's disease,” Brain, 2014. View at Publisher · View at Google Scholar
  • Hooman Ganjavi, D. Louis Collins, Alan C. Evans, and Sherif Karama, “Investigating the relation between striatal volume and IQ,” Brain Imaging and Behavior, vol. 8, no. 1, pp. 52–59, 2014. View at Publisher · View at Google Scholar
  • Claudia Diana Wurster, Heiko Graf, Hermann Ackermann, Katharina Groth, Jan Kassubek, and Axel Riecker, “Neural correlates of rate-dependent finger-tapping in Parkinson’s disease,” Brain Structure and Function, 2014. View at Publisher · View at Google Scholar
  • David P. Marciano, Mi Ra Chang, Cesar A. Corzo, Devrishi Goswami, Vinh Q. Lam, Bruce D. Pascal, and Patrick R. Griffin, “The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs,” Cell Metabolism, 2014. View at Publisher · View at Google Scholar
  • Ahmed A. Moustafa, Rakhee Krishna, Michael J. Frank, Abeer M. Eissa, and Doaa H. Hewedi, “Cognitive correlates of psychosis in patients with Parkinson's disease,” Cognitive Neuropsychiatry, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Samantha Holden, “Treatment of Psychosis and Dementia in Parkinson's Disease,” Current Treatment Options in Neurology, vol. 16, no. 3, 2014. View at Publisher · View at Google Scholar
  • M. J. Socie, B. M. Sandroff, S. Balantrapu, Y. Suh, J. H. Pula, and R. W. Motl, “Mobility and cognitive correlates of dual task cost of walking in persons w ith multiple sclerosis,” Disability and Rehabilitation, vol. 36, no. 3, pp. 205–209, 2014. View at Publisher · View at Google Scholar
  • Alison Talmage, Clare McCann, Laura Fogg, and Suzanne Purdy, “Conceptualizing how group singing may enhance quality of life with Parkinso n's disease,” Disability and Rehabilitation, vol. 36, no. 5, pp. 430–433, 2014. View at Publisher · View at Google Scholar
  • A. Merola, C. A. Artusi, L. Rizzi, S. Angrisano, D. Reggio, C. De Angelis, M. Rizzone, and L. Lopiano, “Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience,” European Journal of Neurology, vol. 21, no. 2, pp. 312–318, 2014. View at Publisher · View at Google Scholar
  • Karen M. Smith, Susan E. Browne, Srinivasan Jayaraman, Carina J. Bleickardt, Lisa M. Hodge, Edward Lis, David Hill, Eric M. Parker, Robert A. Hodgson, Leon Yao, Sunday L. Rittle, Nathalie Innocent, Deborra E. Mullins, George Boykow, and Ian J. Reynolds, “Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Chao Jiang, Ping Liu, Jingsheng Zhang, Wenjing Bao, Shaobo Qiu, Yan Liang, and Lin Jiang, “Clinical Study of Effects of Jian Ji Ning, a Chinese Herbal Medicine Compound Preparation, in Treating Patients with Myasthenia Gravis via the Regulation of Differential MicroRNAs Expression in Serum,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • C. Elaine Little, and Marjorie Woollacott, “Effect of attentional interference on balance recovery in older adults,” Experimental Brain Research, 2014. View at Publisher · View at Google Scholar
  • Jana K. Boller, Michael T. Barbe, K. Amande M. Pauls, Christiane Reck, Matthias Brand, Franziska Maier, Gereon R. Fink, Lars Timmermann, and Elke Kalbe, “Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson’s disease,” Experimental Neurology, 2014. View at Publisher · View at Google Scholar
  • Livia Dezsi, “Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs,” Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 3, pp. 409–424, 2014. View at Publisher · View at Google Scholar
  • Santiago Perez-Lloret, and Marcelo Merello, “Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant,” Expert Opinion on Pharmacotherapy, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Fumitaka Kawakami, Naoki Shimada, Etsuro Ohta, Go Kagiya, Rei Kawashima, Tatsunori Maekawa, and Hiroko Maruyama, “Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct a ctivation of glycogen synthase kinase-3 beta,” Febs Journal, vol. 281, no. 1, pp. 3–13, 2014. View at Publisher · View at Google Scholar
  • Stacey E. Seidl, Jose A. Santiago, Hope Bilyk, and Judith A. Potashkin, “The emerging role of nutrition in Parkinson's disease,” Frontiers in Aging Neuroscience, vol. 6, 2014. View at Publisher · View at Google Scholar
  • Sjoerd M. Bruijn, and Jacques Duysens, “Stride length asymmetry in split-belt locomotion,” Gait & Posture, vol. 39, no. 1, pp. 652–654, 2014. View at Publisher · View at Google Scholar
  • Rianne A. Esselink, Bert J. De Swart, Alexander C. Geurts, Bastiaan R. Bloem, and Vivian Weerdesteyn, “Postural inflexibility in PD: Does it affect compensatory stepping?,” Gait & Posture, vol. 39, no. 2, pp. 700–706, 2014. View at Publisher · View at Google Scholar
  • Kenton R. Kaufman, “The intra-rater reliability and agreement of compensatory stepping threshol ds of healthy subjects,” Gait & Posture, vol. 39, no. 2, pp. 810–815, 2014. View at Publisher · View at Google Scholar
  • Ana Borrajo, Ana I. Rodriguez-Perez, Carmen Diaz-Ruiz, and Maria J. Guerra, “Microglial TNF-alpha Mediates Enhancement of Dopaminergic Degeneration by B rain Angiotensin,” Glia, vol. 62, no. 1, pp. 145–157, 2014. View at Publisher · View at Google Scholar
  • Mary Lou Jackson, Peter J Bex, James M Ellison, Paul Wicks, and Jennifer Wallis, “Feasibility of a Web-Based Survey of Hallucinations and Assessment of Visual Function in Patients With Parkinson’s Disease,” interactive Journal of Medical Research, vol. 3, no. 1, pp. e1, 2014. View at Publisher · View at Google Scholar
  • Pietro Gareri, Alberto Castagna, Davide Francomano, Gregorio Cerminara, and Pasquale De Fazio, “Erectile Dysfunction in the Elderly: An Old Widespread Issue with Novel Treatment Perspectives,” International Journal of Endocrinology, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Robert Wyse, Gary Dunbar, and Julien Rossignol, “Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases,” International Journal of Molecular Sciences, vol. 15, no. 2, pp. 1719–1745, 2014. View at Publisher · View at Google Scholar
  • Peter Valkovic, Jan Harsany, Marta Hanakova, Jana Martinkova, and Jan Benetin, “Nonmotor Symptoms in Early- and Advanced-Stage Parkinson’s Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?,” ISRN Neurology, vol. 2014, pp. 1–4, 2014. View at Publisher · View at Google Scholar
  • Jacki Liddle, David Ireland, Simon J McBride, Sandra G Brauer, Leanne M Hall, Hang Ding, Mohan Karunanithi, Paul W Hodges, Deborah Theodoros, Peter A Silburn, and Helen J Chenery, “Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of Principle,” JMIR mhealth and uhealth, vol. 2, no. 1, pp. e13, 2014. View at Publisher · View at Google Scholar
  • Neil A. Kelly, Matthew P. Ford, David G. Standaert, Ray L. Watts, C. Scott Bickel, Douglas R. Moellering, S. Craig Tuggle, Jeri Y. Williams, Laura Lieb, and Samuel T. Windham, “Novel, high-intensity exercise prescription improves muscle mass, mitochond rial function, and physical capacity in individuals with Parkinson's diseas e,” Journal of Applied Physiology, vol. 116, no. 5, pp. 582–592, 2014. View at Publisher · View at Google Scholar
  • T. Cotechini, M. Komisarenko, A. Sperou, S. Macdonald-Goodfellow, M. A. Adams, and C. H. Graham, “Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia,” Journal of Experimental Medicine, vol. 211, no. 1, pp. 165–179, 2014. View at Publisher · View at Google Scholar
  • Francesco Morichetti, Michael John Strain, Marc Sorel, Paolo Bassi, and Andrea Melloni, “Photonic Integrated Filter With Widely Tunable Bandwidth,” Journal of Lightwave Technology, vol. 32, no. 5, pp. 897–907, 2014. View at Publisher · View at Google Scholar
  • Gyan Modi, Tamara Antonio, and Maarten Reith, “Structural Modifications of Neuroprotective Anti-Parkinsonian (-)-N6-(2-(4- (Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]t hiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Ef ficacy of the Parent Molecule,” Journal of Medicinal Chemistry, vol. 57, no. 4, pp. 1557–1572, 2014. View at Publisher · View at Google Scholar
  • Christina Tremblay, Joël Macoir, Mélanie Langlois, and Laura Monetta, “The role of polysemy on metaphor comprehension processing: The example of Parkinson's disease,” Journal of Neurolinguistics, vol. 30, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Antonino Cannas, Cesare Salvatore Mulas, Silvia Perra, Andrea Corona, Pier Paolo Bassareo, and Francesco Marrosu, “Association between fatigue and other motor and non-motor symptoms in Parki nson's disease patients,” Journal of Neurology, vol. 261, no. 2, pp. 382–391, 2014. View at Publisher · View at Google Scholar
  • Sebastian C. Holst, Alessia Bersagliere, Valerie Bachmann, Wolfgang Berger, and Peter Achermann, “Dopaminergic Role in Regulating Neurophysiological Markers of Sleep Homeost asis in Humans,” Journal of Neuroscience, vol. 34, no. 2, pp. 566–573, 2014. View at Publisher · View at Google Scholar
  • Jiachun Sun, Lina Huang, Qizhi Fu, and Ganqin Du, “Simvastatin prevents neuroinflammation by inhibiting N-methyl-D-aspartic ac id receptor 1 in 6-hydroxydopamine-treated PC12 cells,” Journal of Neuroscience Research, vol. 92, no. 5, pp. 634–640, 2014. View at Publisher · View at Google Scholar
  • Cecile Moro, Nabil El Massri, Napoleon Torres, David Ratel, Xavier De Jaeger, Claude Chabrol, Francois Perraut, Alain Bourgerette, Michel Berger, Sivaraman Purushothuman, Daniel Johnstone, Jonathan Stone, and Alim-Louis Benabid, “Photobiomodulation inside the brain: a novel method of applying near-infrar ed light intracranially and its impact on dopaminergic cell survival in MPT P-treated mice,” Journal of Neurosurgery, vol. 120, no. 3, pp. 670–683, 2014. View at Publisher · View at Google Scholar
  • Victoria Stepien, “Levodopa Fractionation in Parkinson's Disease,” Journal of Parkinsons Disease, vol. 4, no. 1, pp. 89–96, 2014. View at Publisher · View at Google Scholar
  • Uzi Milman, Hagit Atias, Aner Weiss, and Anat Mirelman, “Can Cognitive Remediation Improve Mobility in Patients with Parkinson's Dis ease? Findings from a 12 week Pilot Study,” Journal of Parkinsons Disease, vol. 4, no. 1, pp. 37–44, 2014. View at Publisher · View at Google Scholar
  • Géraldine Hipp, Nico J. Diederich, Vannina Pieria, and Michel Vaillant, “Primary vision and facial emotion recognition in early Parkinson's disease,” Journal of the Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  • Natália Pessoa Rocha, Paula Luciana Scalzo, Izabela Guimarães Barbosa, Mariana Soares de Sousa, Isabela Boechat Morato, Érica Leandro Marciano Vieira, Paulo Pereira Christo, Helton José Reis, and Antônio Lúcio Teixeira, “Circulating levels of adipokines in Parkinson's disease,” Journal of the Neurological Sciences, vol. 339, no. 1-2, pp. 64–68, 2014. View at Publisher · View at Google Scholar
  • Laura E. Halpin, and Stuart A. Collins, “Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine,” Life Sciences, vol. 97, no. 1, pp. 37–44, 2014. View at Publisher · View at Google Scholar
  • R.P. Jones, and D. Goldeck, “Unexpected and unexplained increase in death due to neurological disorders in 2012 in England and Wales: Is cytomegalovirus implicated?,” Medical Hypotheses, 2014. View at Publisher · View at Google Scholar
  • R. Hodge, S. Narasimhan, A. Nall, T. N. Ferraro, B. J. Mickey, M. M. Heitzeg, S. A. Langenecker, J-K Zubieta, R. Bogdan, Y. S. Nikolova, E. Drabant, A. R. Hariri, L. Bevilacqua, D. Goldman, and G. A. Doyle, “Functional genetic variants in the vesicular monoamine transporter 1 modula te emotion processing,” Molecular Psychiatry, vol. 19, no. 1, pp. 129–139, 2014. View at Publisher · View at Google Scholar
  • G. Drui, S. Carnicella, C. Carcenac, M. Favier, A. Bertrand, and S. Boulet, “Loss of dopaminergic nigrostriatal neurons accounts for the motivational an d affective deficits in Parkinson's disease,” Molecular Psychiatry, vol. 19, no. 3, pp. 358–367, 2014. View at Publisher · View at Google Scholar
  • Raymond T. Bartus, and Marc S. Weinberg, “Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Effica cy,” Molecular Therapy, vol. 22, no. 3, pp. 487–497, 2014. View at Publisher · View at Google Scholar
  • Dag Aarsland, John-Paul Taylor, and Daniel Weintraub, “Psychiatric issues in cognitive impairment,” Movement Disorders, vol. 29, no. 5, pp. 651–662, 2014. View at Publisher · View at Google Scholar
  • Jie Du, Xiaoqing Gao, Li Deng, Nengbin Chang, and Huailin Xiong, “Transfection of the glial cell line-derived neurotrophic factor gene promot es neuronal differentiation,” Neural Regeneration Research, vol. 9, no. 1, pp. 33–40, 2014. View at Publisher · View at Google Scholar
  • ChunYan Luo, Wei Song, Qin Chen, ZhenZhen Zheng, Ke Chen, Bei Cao, Jing Yang, JianPeng Li, XiaoQi Huang, and QiYong Gong, “Reduced functional connectivity in early-stage drug-naive Parkinson's disea se: a resting-state fMRI study,” Neurobiology of Aging, vol. 35, no. 2, pp. 431–441, 2014. View at Publisher · View at Google Scholar
  • Eugenie Mutez, Aurore Nkiliza, Karim Belarbi, Amelie de Broucker, Christel Vanbesien-Mailliot, Severine Bleuse, Aurelie Duflot, Thomas Comptdaer, Pierre Semaille, Renaud Blervaque, David Hot, Frederic Lepretre, Martin Figeac, and Alain Destee, “Involvement of the immune system, endocytosis and EIF2 signaling in both ge netically determined and sporadic forms of Parkinson's disease,” Neurobiology of Disease, vol. 63, pp. 165–170, 2014. View at Publisher · View at Google Scholar
  • Marylú Mora, Ernesto Bonilla, Shirley Medina-Leendertz, Yanauri Bravo, and José Luis Arcaya, “Minocycline Increases the Activity of Superoxide Dismutase and Reduces the Concentration of Nitric Oxide, Hydrogen Peroxide and Mitochondrial Malondialdehyde in Manganese Treated Drosophila melanogaster,” Neurochemical Research, 2014. View at Publisher · View at Google Scholar
  • Helton Jose Reis, Pieter Vanden Berghe, and Carla Cirillo, “Depression and Cognitive Impairment in Parkinson's Disease: A Role for Infl ammation and Immunomodulation?,” Neuroimmunomodulation, vol. 21, no. 2-3, pp. 88–94, 2014. View at Publisher · View at Google Scholar
  • Seyed-Mohammad Fereshtehnejad, Farzaneh Farhadi, Hasti Hadizadeh, Gholam Ali Shahidi, Ahmad Delbari, and Johan Lökk, “Cross-Cultural Validity, Reliability, and Psychometric Properties of the Persian Version of the Scales for Outcomes in Parkinson’s Disease-Psychosocial Questionnaire,” Neurology Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Messina, Michele Rizzi, Ivano Dones, and Angelo Franzini, “Cosmetic Posterior Implant of Internal Pulse Generators in Deep Brain Stimulation Procedures: Technical Report,” Neuromodulation: Technology at the Neural Interface, 2014. View at Publisher · View at Google Scholar
  • T. T. Olsson, and P. Brundin, “Review: The future of cell therapies and brain repair: Parkinson's disease leads the way,” Neuropathology and Applied Neurobiology, vol. 40, no. 1, pp. 60–70, 2014. View at Publisher · View at Google Scholar
  • Noelle C. Anastasio, “Serotonin at the nexus of impulsivity and cue reactivity in cocaine addicti on,” Neuropharmacology, vol. 76, pp. 460–478, 2014. View at Publisher · View at Google Scholar
  • Kouji Fukuyama, Shunske Tanahashi, Masamitsu Hoshikawa, and Rika Shinagawa, “Zonisamide regulates basal ganglia transmission via astroglial kynurenine p athway,” Neuropharmacology, vol. 76, pp. 137–145, 2014. View at Publisher · View at Google Scholar
  • Tonya N. Taylor, Shawn P. Alter, Minzheng Wang, and David S. Goldstein, “Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus,” Neuropharmacology, vol. 76, pp. 97–105, 2014. View at Publisher · View at Google Scholar
  • William R. Young, Matthew W.M. Rodger, and Cathy M. Craig, “Auditory observation of stepping actions can cue both spatial and temporal components of gait in Parkinson's disease patients,” Neuropsychologia, 2014. View at Publisher · View at Google Scholar
  • Raphael J. Braga, Chaya B. Gopin, and Anil K. Malhotra, “Dopaminergic Influences on Emotional Decision Making in Euthymic Bipolar Pa tients,” Neuropsychopharmacology, vol. 39, no. 2, pp. 274–282, 2014. View at Publisher · View at Google Scholar
  • A. L. Colin-Gonzalez, A. Luna-Lopez, M. Koenigsberg, S. F. Ali, and J. Pedraza-Chaverri, “Early Modulation Of The Transcription Factor Nrf2 In Rodent Striatal Slices By Quinolinic Acid, A Toxic Metabolite Of The Kynurenine Pathway,” Neuroscience, vol. 260, pp. 130–139, 2014. View at Publisher · View at Google Scholar
  • Lisette Blanco, Carmen María Rosa, Ernesto Tarragón, Emiliano Fernández-Villalba, and María Trinidad Herrero, “Functional Role OF Barringtońs Nucleus in The Micturition Reflex: Relevance in the Surgical Treatment of Parkinson Disease,” Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Tommy Pattij, Ysbrand D. van der Werf, Pieter Voorn, Jan Booij, Sonja Rutten, Henk W. Berendse, and Odile A. van den Heuvel, “Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin?,” Neuroscience and Biobehavioral Reviews, vol. 38, pp. 60–71, 2014. View at Publisher · View at Google Scholar
  • Christopher S. Coffey, Alberto Albanese, Ken Cheung, Cynthia L. Comella, Dixie J. Ecklund, Stanley Fahn, Joseph Jankovic, Karl Kieburtz, Anthony E. Lang, Michael P. McDermott, Jeremy M. Shefner, Jan K. Teller, John L. P. Thompson, Sharon D. Yeatts, and H. A. Jinnah, “Designing Clinical Trials for Dystonia,” Neurotherapeutics, vol. 11, no. 1, pp. 117–127, 2014. View at Publisher · View at Google Scholar
  • Sergio Montes, Susana Rivera-Mancia, Araceli Diaz-Ruiz, Luis Tristan-Lopez, and Camilo Rios, “Copper and Copper Proteins in Parkinson’s Disease,” Oxidative Medicine and Cellular Longevity, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Michelle S. Troche, Michael S. Okun, John C. Rosenbek, Lori J. Altmann, and Christine M. Sapienza, “Attentional Resource Allocation and Swallowing Safety in Parkinson’s Disease: A Dual Task Study,” Parkinsonism & Related Disorders, 2014. View at Publisher · View at Google Scholar
  • Roberta Biundo, Luca Weis, Silvia Facchini, Patrizia Formento-Dojot, Annamaria Vallelunga, Manuela Pilleri, and Angelo Antonini, “Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia,” Parkinsonism & Related Disorders, 2014. View at Publisher · View at Google Scholar
  • George T. Gitchel, Paul A. Wetzel, Abu Qutubuddin, and Mark S. Baron, “Experimental support that ocular tremor in Parkinson’s disease does not originate from head movement,” Parkinsonism & Related Disorders, 2014. View at Publisher · View at Google Scholar
  • Shahrul Azmin, Abdul Manaf Khairul Anuar, Hui Jan Tan, Wan Yahya Nafisah, Azman Ali Raymond, Othman Hanita, Shamsul Azhar Shah, and Mohamed Ibrahim Norlinah, “Nonmotor Symptoms in a Malaysian Parkinson’s Disease Population,” Parkinson's Disease, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Seong-Mook Kang, Sandeep Vasant More, Ju-Young Park, Byung-Wook Kim, Sung-Hwa Yoon, and Dong-Kug Choi, “A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways,” Pharmacological Reports, 2014. View at Publisher · View at Google Scholar
  • Sachi O'Hoski, Bonnie Winship, Lauren Herridge, Tainnoor Agha, Dina Brooks, and Marla K. Beauchamp, “Increasing the Clinical Utility of the BESTest, Mini-BESTest, and Brief-BES Test: Normative Values in Canadian Adults Who Are Healthy and Aged 50 Years or Older,” Physical Therapy, vol. 94, no. 3, pp. 334–342, 2014. View at Publisher · View at Google Scholar
  • Wim Mandemakers, Francis Jolivette, Laetitia Coudert, Rachid Mazroui, Bart De Strooper, and Sebastien S. Hebert, “Gene and MicroRNA Transcriptome Analysis of Parkinson's Related LRRK2 Mouse Models,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Timothy Rittman, Trevor W. Robbins, and James B. Rowe, “Multiple Modes of Impulsivity in Parkinson's Disease,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Marco Monaco, Silvia Zabberoni, Antonella Peppe, Roberta Perri, Lucia Fadda, Francesca Iannarelli, Carlo Caltagirone, and Giovanni A. Carlesimo, “Free and Cued Recall Memory in Parkinson's Disease Associated with Amnestic Mild Cognitive Impairment,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • T. W. Chohan, A. A. Boucher, J. R. Spencer, M. S. Kassem, A. A. Hamdi, T. Karl, S. Y. Fok, M. R. Bennett, and J. C. Arnold, “Partial Genetic Deletion of Neuregulin 1 Modulates the Effects of Stress on Sensorimotor Gating, Dendritic Morphology, and HPA Axis Activity in Adolescent Mice,” Schizophrenia Bulletin, 2014. View at Publisher · View at Google Scholar
  • Gregory L. Willis, Cleo Moore, and Stuart Maxwell Armstrong, “Parkinson's Disease, Lights and Melanocytes: Looking Beyond the Retina,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • Johanna Neuner, Severin Filser, Stylianos Michalakis, Martin Biel, and Jochen Herms, “A30P α-Synuclein interferes with the stable integration of adult-born neurons into the olfactory network,” Scientific Reports, vol. 4, 2014. View at Publisher · View at Google Scholar
  • V. Richter, C. S. Palmer, L. D. Osellame, A. P. Singh, K. Elgass, D. A. Stroud, H. Sesaki, M. Kvansakul, and M. T. Ryan, “Structural and functional analysis of MiD51, a dynamin receptor required for mitochondrial fission,” The Journal of Cell Biology, 2014. View at Publisher · View at Google Scholar
  • Stefania Romeo, Daniela Di Camillo, Alessandra Splendiani, Marta Capannolo, Cristina Rocchi, Gabriella Aloisi, Irene Fasciani, Giovanni U. Corsini, Eugenio Scarnati, Luca Lozzi, and Roberto Maggio, “Eyes as Gateways for Environmental Light to the Substantia Nigra: Relevance in Parkinson’s Disease,” The Scientific World Journal, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Xiangbao Meng, Min Wang, Guibo Sun, Jingxue Ye, Yanhui Zhou, Xi Dong, Tingting Wang, Shan Lu, and Xiaobo Sun, “Attenuation of Aβ25–35-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE pathways,” Toxicology and Applied Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Anna Przekoracka-Krawczyk, Paweł Nawrot, Monika Czaińska, and Krzysztof Piotr Michalak, “Impaired body balance control in adults with strabismus,” Vision Research, 2014. View at Publisher · View at Google Scholar
  • Eva-Juliane Vollstedt, and Christine Klein, “Early Signs and Neuropsychiatric Symptoms in Parkinson's Disease,” Zeitschrift Fur Neuropsychologie, vol. 25, no. 1, pp. 31–38, 2014. View at Publisher · View at Google Scholar
  • Heidemarie Zach, Doris Moser, Andreas Gleiss, Eduard Auff, Walter Pirker, and Gisela Pusswald, “Prevalence of Mild Cognitive Impairment Subtypes in Patients with Parkinson 's Disease - Comparison of two Modes of Classification,” Zeitschrift Fur Neuropsychologie, vol. 25, no. 1, pp. 49–63, 2014. View at Publisher · View at Google Scholar
  • S. Navailles, M. Lagiere, A. Contini, and P. De Deurwaerdere, “Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Indu ced Dopamine and Serotonin Release in the Parkinsonian Brain,” Acs Chemical Neuroscience, vol. 4, no. 5, pp. 680–692, 2013. View at Publisher · View at Google Scholar
  • Marina Spanos, Julie Gras-Najjar, Jeremy M. Letchworth, Audrey L. Sanford, J. Vincent Toups, and Leslie A. Sombers, “Quantitation of Hydrogen Peroxide Fluctuations and Their Modulation of Dopamine Dynamics in the Rat Dorsal Striatum Using Fast-Scan Cyclic Voltammetry,” ACS Chemical Neuroscience, vol. 4, no. 5, pp. 782–789, 2013. View at Publisher · View at Google Scholar
  • B. Muller, J. Assmus, J. P. Larsen, K. Haugarvoll, G. O. Skeie, and O. -B. Tysnes, “Autonomic symptoms and dopaminergic treatment in de novo Parkinson's diseas e,” Acta Neurologica Scandinavica, vol. 127, no. 4, pp. 290–294, 2013. View at Publisher · View at Google Scholar
  • X. Y. Mao, N. N. Li, E. K. Tan, J. H. Zhang, X. L. Chang, D. M. Zhao, and Q. Liao, “MCCC1/LAMP3 reduces risk of sporadic Parkinson's disease in Han Chinese,” Acta Neurologica Scandinavica, vol. 128, no. 2, pp. 136–139, 2013. View at Publisher · View at Google Scholar
  • Jon B. Toledo, Ane Korff, Leslie M. Shaw, John Q. Trojanowski, and Jing Zhang, “CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease,” Acta Neuropathologica, 2013. View at Publisher · View at Google Scholar
  • Hamdolah Sharifi, Alireza Mohajjel Nayebi, and Safar Farajnia, “Dose-dependent effect of flouxetine on 6-OHDA-induced catalepsy in male rats: A possible involvement of 5-HT1A receptors,” Advanced Pharmaceutical Bulletin, vol. 3, no. 1, pp. 203–206, 2013. View at Publisher · View at Google Scholar
  • Colin Cook, Paul G. Shiels, Stephen D. Lawn, and Clare Gilbert, “The eye as a model of ageing in translational research - Molecular, epigene tic and clinical aspects,” Ageing Research Reviews, vol. 12, no. 2, pp. 490–508, 2013. View at Publisher · View at Google Scholar
  • Maria H. Nilsson, and Susanne Iwarsson, “Characteristics of the personal and environmental components of person-envi ronment fit in very old age: a comparison between people with self-reported Parkinson's disease and matched controls,” Aging Clinical and Experimental Research, vol. 25, no. 6, pp. 667–675, 2013. View at Publisher · View at Google Scholar
  • Audrey McKinlay, “A review of cognitive and other non-motor problems in Parkinson's disease,” Aging Health, vol. 9, no. 1, pp. 89–102, 2013. View at Publisher · View at Google Scholar
  • Nikhil Satchidanand, Chester Fox, Kimberly Brunton, Jo Freudenheim, James Hassett, Bruce Naughton, and Gregory S Cherr, “Exploring predictors of walking ability among community-dwelling older adults,” Aging Health, vol. 9, no. 2, pp. 189–197, 2013. View at Publisher · View at Google Scholar
  • P. Vieregge, J. B. Schulz, R. Hilker, M. Wolz, B. Herting, D. Woitalla, and H. Reichmann, “Parkinson Syndrome(s) - New Concepts for a Spreading Disease?,” Aktuelle Neurologie, vol. 40, no. 6, pp. 327–332, 2013. View at Publisher · View at Google Scholar